Concepedia

Author

Trevor Beattie

Aurum Institute

Also Known As

Heeran Makkan, T Beattie, Trevor Beattie

16

Publications

300

Citations

6

H-Index

7

Concepts

All Affiliations

Aurum InstituteUniversity of the WitwatersrandLondon School of Hygiene & Tropical MedicineUniversity of Cape TownPerinatal HIV Research Unit
TB

About

Trevor Beattie is an author at Aurum Institute specializing in hiv, tuberculosis, and drug resistance.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

65

2

Pharmacology

1

1

65

3

Drug Resistance

1

1

65

4

Tuberculosis

1

1

65

5

Hiv

1

1

65

Trevor Beattie

×

5

Publications

279

Citations

5

H-Index

YearCitations

Adjunctive host-directed therapies for pulmonary tuberculosis: a prospective, open-label, phase 2, randomised controlled trial

Robert S. Wallis, Sibuse Ginindza, Trevor Beattie,

The Lancet Respiratory Medicine

2021

123

Once-weekly rifapentine and isoniazid for tuberculosis prevention in patients with HIV taking dolutegravir-based antiretroviral therapy: a phase 1/2 trial

Kelly E. Dooley, Radojkam Savic, Akshay Gupte,

The Lancet HIV

2020

65

Safety and Immunogenicity of H1/IC31®, an Adjuvanted TB Subunit Vaccine, in HIV-Infected Adults with CD4+ Lymphocyte Counts Greater than 350 cells/mm3: A Phase II, Multi-Centre, Double-Blind, Randomized, Placebo-Controlled Trial

Klaus Reither, L. Katsoulis, Trevor Beattie,

PLoS ONE

2014

58

Lung and blood early biomarkers for host-directed tuberculosis therapies: Secondary outcome measures from a randomized controlled trial

Robert S. Wallis, Sibuse Ginindza, Trevor Beattie,

PLoS ONE

2022

17

Safety, bactericidal activity, and pharmacokinetics of the antituberculosis drug candidate BTZ-043 in South Africa (PanACEA-BTZ-043–02): an open-label, dose-expansion, randomised, controlled, phase 1b/2a trial

Norbert Heinrich, Veronique de Jager, Julia Dreisbach,

The Lancet Microbe

2025

16

Page 1